1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Russia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Russia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "Russia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Russia In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the Russia In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Russia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 12
2.1 What Is This Report About? 12
2.2 In Vitro Diagnostics Market Segmentation 12
2.3 Definitions of Markets Covered in the Report 15
3 In Vitro Diagnostics Market, Russia 28
3.1 In Vitro Diagnostics Market, Russia, Revenue ($m), 2007-2021 28
3.2 In Vitro Diagnostics Market, Russia, Revenue Mix ($m), 2014 30
3.3 In Vitro Diagnostics Market, Russia, Category Contribution by Revenue ($m), 2014 31
3.4 In Vitro Diagnostics Market, Russia, Category Comparison by Revenue ($m), 2007-2021 33
3.5 In Vitro Diagnostics Market, Russia, Revenue ($m), 2007-2014 35
3.6 In Vitro Diagnostics Market, Russia, Revenue ($m), 2014-2021 37
3.7 In Vitro Diagnostics Market, Russia, Company Share by Revenue ($m), 2014 39
4 Clinical Chemistry Market, Russia 41
4.1 Clinical Chemistry Market, Russia, Revenue Mix ($m), 2014 41
4.2 Clinical Chemistry Market, Russia, Segment Contribution (%), 2014 42
4.3 Clinical Chemistry Market, Russia, Revenue ($m), 2007-2014 43
4.4 Clinical Chemistry Market, Russia, Revenue ($m), 2014-2021 45
4.4.1 Clinical Chemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2007-2014 47
4.4.2 Therapeutic Drug Monitoring Market, Russia, Revenue ($m), by Segment, 2007-2014 49
4.4.3 Urine Analysis Market, Russia, Revenue ($m), by Segment, 2007-2014 51
4.4.4 Clinical Chemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2014-2021 53
4.4.5 Therapeutic Drug Monitoring Market, Russia, Revenue ($m), by Segment, 2014-2021 55
4.4.6 Urine Analysis Market, Russia, Revenue ($m), by Segment, 2014-2021 57
4.5 Clinical Chemistry Market, Russia, Distribution Share by Revenue ($m), 2013-2014 59
4.6 Clinical Chemistry Market, Russia, Company Share by Revenue ($m), 2014 60
5 Genetic Testing Market, Russia 62
5.1 Genetic Testing Market, Russia, Revenue Mix ($m), 2014 62
5.2 Genetic Testing Market, Russia, Segment Contribution (%), 2014 63
5.3 Genetic Testing Market, Russia, Revenue ($m), 2007-2014 64
5.4 Genetic Testing Market, Russia, Revenue ($m), 2014-2021 66
5.5 Genetic Testing Market, Russia, Distribution Share by Revenue ($m), 2013-2014 68
5.6 Genetic Testing Market, Russia, Company Share by Revenue ($m), 2014 69
6 Haematology Market, Russia 71
6.1 Haematology Market, Russia, Revenue Mix ($m), 2014 71
6.2 Haematology Market, Russia, Segment Contribution (%), 2014 72
6.3 Haematology Market, Russia, Revenue ($m), 2007-2014 73
6.4 Haematology Market, Russia, Revenue ($m), 2014-2021 75
6.4.1 Haematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2007-2014 77
6.4.2 Haematology Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2007-2014 79
6.4.3 Haematology Reagents Market, Russia, Revenue ($m), by Segment, 2007-2014 81
6.4.4 Haemostasis Market, Russia, Revenue ($m), by Segment, 2007-2014 83
6.4.5 Immunohaematology Market, Russia, Revenue ($m), by Segment, 2007-2014 85
6.4.6 Haematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2014-2021 87
6.4.7 Haematology Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2014-2021 89
6.4.8 Haematology Reagents Market, Russia, Revenue ($m), by Segment, 2014-2021 91
6.4.9 Haemostasis Market, Russia, Revenue ($m), by Segment, 2014-2021 93
6.4.10 Immunohaematology Market, Russia, Revenue ($m), by Segment, 2014-2021 95
6.5 Haematology Market, Russia, Distribution Share by Revenue ($m), 2013-2014 97
6.6 Haematology Market, Russia, Company Share by Revenue ($m), 2014 98
7 Histology And Cytology Market, Russia 100
7.1 Histology And Cytology Market, Russia, Revenue Mix ($m), 2014 100
7.2 Histology And Cytology Market, Russia, Segment Contribution (%), 2014 101
7.3 Histology And Cytology Market, Russia, Revenue ($m), 2007-2014 102
7.4 Histology And Cytology Market, Russia, Revenue ($m), 2014-2021 104
7.5 Histology And Cytology Market, Russia, Distribution Share by Revenue ($m), 2013-2014 106
7.6 Histology And Cytology Market, Russia, Company Share by Revenue ($m), 2014 107
8 Immuno Chemistry Market, Russia 109
8.1 Immuno Chemistry Market, Russia, Revenue Mix ($m), 2014 109
8.2 Immuno Chemistry Market, Russia, Segment Contribution (%), 2014 110
8.3 Immuno Chemistry Market, Russia, Revenue ($m), 2007-2014 112
8.4 Immuno Chemistry Market, Russia, Revenue ($m), 2014-2021 114
8.4.1 Anemia Tests Market, Russia, Revenue ($m), by Segment, 2007-2014 116
8.4.2 Disease Specific Immunochemistry Market, Russia, Revenue ($m), by Segment, 2007-2014 118
8.4.3 Endocrinology Tests Market, Russia, Revenue ($m), by Segment, 2007-2014 120
8.4.4 IgE Allergy Blood Tests Market, Russia, Revenue ($m), by Segment, 2007-2014 122
8.4.5 Immunochemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2007-2014 124
8.4.6 Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2007-2014 126
8.4.7 Vitamins Tests Market, Russia, Revenue ($m), by Segment, 2007-2014 128
8.4.8 Anemia Tests Market, Russia, Revenue ($m), by Segment, 2014-2021 130
8.4.9 Disease Specific Immunochemistry Market, Russia, Revenue ($m), by Segment, 2014-2021 132
8.4.10 Endocrinology Tests Market, Russia, Revenue ($m), by Segment, 2014-2021 134
8.4.11 IgE Allergy Blood Tests Market, Russia, Revenue ($m), by Segment, 2014-2021 136
8.4.12 Immunochemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2014-2021 138
8.4.13 Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2014-2021 140
8.4.14 Vitamins Tests Market, Russia, Revenue ($m), by Segment, 2014-2021 142
8.5 Immuno Chemistry Market, Russia, Distribution Share by Revenue ($m), 2013-2014 144
8.6 Immuno Chemistry Market, Russia, Company Share by Revenue ($m), 2014 145
9 Infectious Diagnostics Market, Russia 147
9.1 Infectious Diagnostics Market, Russia, Revenue Mix ($m), 2014 147
9.2 Infectious Diagnostics Market, Russia, Segment Contribution (%), 2014 148
9.3 Infectious Diagnostics Market, Russia, Revenue ($m), 2007-2014 150
9.4 Infectious Diagnostics Market, Russia, Revenue ($m), 2014-2021 152
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2007-2014 154
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2014-2021 156
9.5 Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), 2013-2014 158
9.6 Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), 2014 159
10 Microbiology Culture Market, Russia 161
10.1 Microbiology Culture Market, Russia, Revenue Mix ($m), 2014 161
10.2 Microbiology Culture Market, Russia, Segment Contribution (%), 2014 162
10.3 Microbiology Culture Market, Russia, Revenue ($m), 2007-2014 164
10.4 Microbiology Culture Market, Russia, Revenue ($m), 2014-2021 166
10.4.1 Microbiology Analyzers Market, Russia, Revenue ($m), by Segment, 2007-2014 168
10.4.2 Microbiology Analyzers Market, Russia, Revenue ($m), by Segment, 2014-2021 170
10.5 Microbiology Culture Market, Russia, Distribution Share by Revenue ($m), 2013-2014 172
10.6 Microbiology Culture Market, Russia, Company Share by Revenue ($m), 2014 173
11 Overview of Key Companies in Russia, In Vitro Diagnostics Market 175
11.1 Siemens Healthcare 175
11.1.1 Company Overview 175
11.2 F. Hoffmann-La Roche Ltd. 175
11.2.1 Company Overview 175
11.3 Abbott Laboratories 175
11.3.1 Company Overview 175
11.4 Danaher Corporation 176
11.4.1 Company Overview 176
11.5 bioMerieux S.A. 176
11.5.1 Company Overview 176
11.6 Becton, Dickinson and Company 176
11.6.1 Company Overview 176
11.7 Sysmex Corporation 177
11.7.1 Company Overview 177
11.8 Alere Inc. 177
11.8.1 Company Overview 177
11.9 Bio-Rad Laboratories, Inc. 177
11.9.1 Company Overview 177
11.10 Thermo Fisher Scientific Inc. 178
11.10.1 Company Overview 178
11.11 Ortho-Clinical Diagnostics Inc. 179
11.11.1 Company Overview 179
12 In Vitro Diagnostics Market Pipeline Products 180
13 Financial Deals Landscape 186
13.1 Partnerships 186
13.1.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 186
13.1.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 187
13.1.3 MdxHealth Enters into Licensing Agreement with Erasmus MC 188
13.1.4 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 189
13.1.5 Sigma-Aldrich Enters into Distribution Agreement with LGC 190
13.1.6 OvaGene Oncology Enters into Agreement with Etta Healthcare 191
13.1.7 InTouch Health Enters into Agreement with iSchemaView 192
13.1.8 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 193
13.1.9 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 194
13.1.10 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 195
13.1.11 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 196
13.1.12 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 197
13.1.13 AngioDynamics Enters into Licensing Agreement with EmboMedics 198
13.1.14 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 199
13.1.15 Orphee Terminates Distribution Agreement with PZ Cormay 200
13.1.16 Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 201
13.1.17 Biocartis Enters into Licensing and Development Agreement with Microbiome 202
13.1.18 Esperite Enters into Agreement with Premaitha Health 203
13.1.19 CBScientific Enters into Distribution Agreement with UTest 204
13.1.20 Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 205
13.1.21 GeneThera Enters into Co-Development Agreement with Hudson Robotics 206
13.1.22 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 207
13.1.23 Ellen Enters into Distribution Agreement with Biosynex 208
13.1.24 KromaTiD Enters into Distribution Agreement with Tebu-bio 209
13.1.25 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 210
13.1.26 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 212
13.1.27 BioMerieux Enters into Licensing Agreement with Astute Medical 213
13.1.28 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 214
13.1.29 NoemaLife Enters into Distribution Agreement with Horiba Medical 215
13.1.30 Clinical Genomics Enters into Licensing Agreement with CSIRO 216
14 Recent Developments 217
14.1 Strategy And Business Planning 217
14.1.1 Apr 10, 2015: Novo Nordisk opens new insulin formulation and filling facility in Russia 217
15 Appendix 218
15.1 Research Methodology 219
15.1.1 Coverage 219
15.1.2 Secondary Research 219
15.1.3 Primary Research 219
15.1.4 Company Share Analysis 220
15.1.5 Distribution Share Analysis 220
15.2 GlobalData Consulting 220
15.3 Contact Us 220
15.4 Disclaimer 221

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, 2007-2021 29
Table 2: In Vitro Diagnostics Market, Russia, Category Contribution by Revenue ($m), 2014 32
Table 3: In Vitro Diagnostics Market, Russia, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Table 4: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 5: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 6: In Vitro Diagnostics Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 40
Table 7: Clinical Chemistry Market, Russia, Segment Contribution (%), 2014 42
Table 8: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 44
Table 9: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Table 10: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 48
Table 11: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 12: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 13: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Table 14: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 15: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 16: Clinical Chemistry Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 59
Table 17: Clinical Chemistry Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 61
Table 18: Genetic Testing Market, Russia, Segment Contribution (%), 2014 63
Table 19: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 65
Table 20: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Table 21: Genetic Testing Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 68
Table 22: Genetic Testing Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 70
Table 23: Haematology Market, Russia, Segment Contribution (%), 2014 72
Table 24: Haematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 74
Table 25: Haematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Table 26: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 78
Table 27: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 28: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 29: Haemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 30: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 31: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 88
Table 32: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Table 33: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Table 34: Haemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 35: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 36: Haematology Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 97
Table 37: Haematology Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 99
Table 38: Histology And Cytology Market, Russia, Segment Contribution (%), 2014 101
Table 39: Histology And Cytology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 103
Table 40: Histology And Cytology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 105
Table 41: Histology And Cytology Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 106
Table 42: Histology And Cytology Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 108
Table 43: Immuno Chemistry Market, Russia, Segment Contribution (%), 2014 111
Table 44: Immuno Chemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 113
Table 45: Immuno Chemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 115
Table 46: Anemia Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 117
Table 47: Disease Specific Immunochemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 119
Table 48: Endocrinology Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 49: IgE Allergy Blood Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 50: Immunochemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 51: Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 52: Vitamins Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 53: Anemia Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 131
Table 54: Disease Specific Immunochemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Table 55: Endocrinology Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 56: IgE Allergy Blood Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 57: Immunochemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 58: Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 59: Vitamins Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 60: Immuno Chemistry Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 144
Table 61: Immuno Chemistry Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 146
Table 62: Infectious Diagnostics Market, Russia, Segment Contribution (%), 2014 149
Table 63: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 151
Table 64: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Table 65: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 155
Table 66: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Table 67: Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 158
Table 68: Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 160
Table 69: Microbiology Culture Market, Russia, Segment Contribution (%), 2014 163
Table 70: Microbiology Culture Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 165
Table 71: Microbiology Culture Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 167
Table 72: Microbiology Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 169
Table 73: Microbiology Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Table 74: Microbiology Culture Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 172
Table 75: Microbiology Culture Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 174
Table 76: In Vitro Diagnostics Market Pipeline Products 180
Table 77: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 186
Table 78: Seegene Enters into Co-Development Agreement with BD Life Sciences 187
Table 79: MdxHealth Enters into Licensing Agreement with Erasmus MC 188
Table 80: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 189
Table 81: Sigma-Aldrich Enters into Distribution Agreement with LGC 190
Table 82: OvaGene Oncology Enters into Agreement with Etta Healthcare 191
Table 83: InTouch Health Enters into Agreement with iSchemaView 192
Table 84: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 193
Table 85: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 194
Table 86: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 195
Table 87: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 196
Table 88: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 197
Table 89: AngioDynamics Enters into Licensing Agreement with EmboMedics 198
Table 90: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 199
Table 91: Orphee Terminates Distribution Agreement with PZ Cormay 200
Table 92: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 201
Table 93: Biocartis Enters into Licensing and Development Agreement with Microbiome 202
Table 94: Esperite Enters into Agreement with Premaitha Health 203
Table 95: CBScientific Enters into Distribution Agreement with UTest 204
Table 96: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 205
Table 97: GeneThera Enters into Co-Development Agreement with Hudson Robotics 206
Table 98: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 207
Table 99: Ellen Enters into Distribution Agreement with Biosynex 208
Table 100: KromaTiD Enters into Distribution Agreement with Tebu-bio 209
Table 101: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 210
Table 102: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 212
Table 103: BioMerieux Enters into Licensing Agreement with Astute Medical 213
Table 104: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 214
Table 105: NoemaLife Enters into Distribution Agreement with Horiba Medical 215
Table 106: Clinical Genomics Enters into Licensing Agreement with CSIRO 216

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, 2007-2021 28
Figure 2: In Vitro Diagnostics Market, Russia, Revenue Mix ($m), 2014 30
Figure 3: In Vitro Diagnostics Market, Russia, Category Contribution (%), 2014 31
Figure 4: In Vitro Diagnostics Market, Russia, Category Comparison by Revenue ($m), USD Constant, 2007-2021 33
Figure 5: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 6: In Vitro Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 7: In Vitro Diagnostics Market, Russia, Company Share (%) 2014 39
Figure 8: Clinical Chemistry Market, Russia, Revenue Mix ($m), 2014 41
Figure 9: Clinical Chemistry Market, Russia, Segment Contribution (%), 2014 42
Figure 10: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 43
Figure 11: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Figure 12: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 47
Figure 13: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 14: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 15: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Figure 16: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 17: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 18: Clinical Chemistry Market, Russia, Company Share (%) 2014 60
Figure 19: Genetic Testing Market, Russia, Revenue Mix ($m), 2014 62
Figure 20: Genetic Testing Market, Russia, Segment Contribution (%), 2014 63
Figure 21: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 64
Figure 22: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 66
Figure 23: Genetic Testing Market, Russia, Company Share (%) 2014 69
Figure 24: Haematology Market, Russia, Revenue Mix ($m), 2014 71
Figure 25: Haematology Market, Russia, Segment Contribution (%), 2014 72
Figure 26: Haematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 73
Figure 27: Haematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Figure 28: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 77
Figure 29: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 30: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 31: Haemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 32: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 33: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 87
Figure 34: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Figure 35: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Figure 36: Haemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 37: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 38: Haematology Market, Russia, Company Share (%) 2014 98
Figure 39: Histology And Cytology Market, Russia, Revenue Mix ($m), 2014 100
Figure 40: Histology And Cytology Market, Russia, Segment Contribution (%), 2014 101
Figure 41: Histology And Cytology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 102
Figure 42: Histology And Cytology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 104
Figure 43: Histology And Cytology Market, Russia, Company Share (%) 2014 107
Figure 44: Immuno Chemistry Market, Russia, Revenue Mix ($m), 2014 109
Figure 45: Immuno Chemistry Market, Russia, Segment Contribution (%), 2014 110
Figure 46: Immuno Chemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 112
Figure 47: Immuno Chemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 114
Figure 48: Anemia Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 116
Figure 49: Disease Specific Immunochemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 118
Figure 50: Endocrinology Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 51: IgE Allergy Blood Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 122
Figure 52: Immunochemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 53: Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 54: Vitamins Tests Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 55: Anemia Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 130
Figure 56: Disease Specific Immunochemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Figure 57: Endocrinology Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 58: IgE Allergy Blood Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Figure 59: Immunochemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 60: Immunochemistry Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 61: Vitamins Tests Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 62: Immuno Chemistry Market, Russia, Company Share (%) 2014 145
Figure 63: Infectious Diagnostics Market, Russia, Revenue Mix ($m), 2014 147
Figure 64: Infectious Diagnostics Market, Russia, Segment Contribution (%), 2014 148
Figure 65: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 150
Figure 66: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 152
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 154
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Figure 69: Infectious Diagnostics Market, Russia, Company Share (%) 2014 159
Figure 70: Microbiology Culture Market, Russia, Revenue Mix ($m), 2014 161
Figure 71: Microbiology Culture Market, Russia, Segment Contribution (%), 2014 162
Figure 72: Microbiology Culture Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 164
Figure 73: Microbiology Culture Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 166
Figure 74: Microbiology Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 168
Figure 75: Microbiology Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Figure 76: Microbiology Culture Market, Russia, Company Share (%) 2014 173

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.